medroxyprogesterone acetate has been researched along with Meningioma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altinoz, MA; Elmaci, I; Ozpinar, A | 1 |
| Hensiek, AE; Hill, JT; Kellerman, AJ | 1 |
| Markwalder, TM; Waelti, ER | 1 |
| Haltia, M; Jääskeläinen, J; Kärkkäinen, J; Laasonen, E; Troupp, H | 1 |
| König, MP; Markwalder, TM; Waelti, E | 1 |
| Gerber, HA; Markwalder, RV; Markwalder, TM; Schaffner, T; Waelti, E | 1 |
1 review(s) available for medroxyprogesterone acetate and Meningioma
| Article | Year |
|---|---|
Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma.
Topics: Animals; Antineoplastic Agents, Hormonal; Brain Neoplasms; Female; Glioma; Hormone Antagonists; Humans; Medroxyprogesterone Acetate; Meningioma; Mifepristone; Norpregnadienes; Progesterone; Progestins; Receptors, Progesterone | 2019 |
5 other study(ies) available for medroxyprogesterone acetate and Meningioma
| Article | Year |
|---|---|
Spontaneous regression of a solitary cerebral metastases in renal carcinoma followed by meningioma development under medroxyprogesterone acetate therapy.
Topics: Adult; Antineoplastic Agents, Hormonal; Brain Neoplasms; Carcinoma, Renal Cell; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Medroxyprogesterone Acetate; Meningioma; Neoplasm Regression, Spontaneous; Neoplasms, Second Primary | 2000 |
Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on growth of primary meningioma cells in monolayer tissue culture.
Topics: Antigens, Surface; Cell Division; Culture Techniques; Endocrine Glands; Humans; Immunohistochemistry; Ki-67 Antigen; Medroxyprogesterone; Medroxyprogesterone Acetate; Meningeal Neoplasms; Meningioma; Receptors, Progesterone; Tumor Cells, Cultured | 1989 |
Hormone treatment of meningiomas: lack of response to medroxyprogesterone acetate (MPA). A pilot study of five cases.
Topics: Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Meningeal Neoplasms; Meningioma; Middle Aged; Pilot Projects; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tomography, X-Ray Computed | 1986 |
Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on receptor status of meningioma cytosols.
Topics: Cytosol; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Meningeal Neoplasms; Meningioma; Middle Aged; Pilot Projects; Receptors, Estrogen; Receptors, Progesterone | 1987 |
Hormonotherapy of meningiomas with medroxyprogesterone acetate. Immunohistochemical demonstration of the effect of medroxyprogesterone acetate on growth fractions of meningioma cells using the monoclonal antibody Ki-67.
Topics: Antibodies, Monoclonal; Drug Evaluation; Growth Substances; Humans; Immunoenzyme Techniques; Immunohistochemistry; Medroxyprogesterone; Medroxyprogesterone Acetate; Meningeal Neoplasms; Meningioma; Neoplasm Proteins; Peptides; Preoperative Care; Receptors, Progesterone; Reoperation; Time Factors; Transforming Growth Factors | 1988 |